Citigroup provided rating and price targets for ProQR Therapeutics stock.
1 report, 1 independent
Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup provided rating and price targets for ProQR Therapeutics stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
Related events
- Multiple financial firms, including Citigroup and Truist Financial, issued rating changes, price targets, and stake acquisitions related to C. H. Robinson Worldwide.
- Citigroup restated a buy rating on shares of Intensity Therapeutics.
- Citigroup boosted its price target and gave a buy rating for Wholesale Club, with MarketBeat providing consensus data.
- Citigroup and Jefferies Financial Group provided analyst ratings and price targets for BHP Group stock.
- Citigroup reaffirmed a buy rating, Susquehanna raised its price objective, and MarketBeat provided ratings for Royal Caribbean International.